1-20 of 24
Eva González-Barca
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Assessment of Minimal Residual Disease Levels in B-CLL After Front-Line Treatment with FC-R and Rituximab Maintenance

Free
Jose A. Garcia-Vela, MD, Javier Lopez, Secundino Ferrer, Pilar Giraldo, Eva González-Barca, Eulogio Conde, Marcos González, Jose-Luis Guzman, Javier De la Serna, MD, PhD, Mar Osma, MD, Guillermo Deben, MD, Encarna Monzo, MD, Raquel De Paz, MD, Francisco-Javier Penalver, Isidro Jarque, MD, Rafael Martinez, MD, Carmen Burgaleta, Jaime Perez de Oteiza, MD, M.Angeles Andreu, MD, Felix Carbonell, MD, Jose A Garcia-Marco
Journal: Blood
Blood (2012) 120 (21): 4599.
https://doi.org/10.1182/blood.V120.21.4599.4599
Published: 2012
Journal Articles

Prognostic Impact of the MRD Status After Induction Treatment with Rituximab Plus Fludarabine, Cyclophosphamide and Mitoxantrone (R-FCM) in Patients with Chronic Lymphocytic Leukemia Receiving Rituximab Maintenance Therapy

Free
Pau Abrisqueta, MD, Neus Villamor, MD, PhD, María José Terol, MD, PhD, Eva González-Barca, MD, PhD, Marcos González, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose Antonio García-Marco, MD, PhD, Yolanda González, MD, Felix Carbonell, MD, PhD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, MD, Ana Muntanola, MD, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD, Francesc Bosch, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3930.
https://doi.org/10.1182/blood.V120.21.3930.3930
Published: 2012
Journal Articles

Efficacy of Autologous Stem-Cell Transplantation in Patients with Relapsed or Refractory Aggressive B-Cell Lymphoma in the Rituximab Era. A Multicenter Geltamo Study.

Free
Alba María Redondo, Alejandro Martín, Helena Pomares, María Jesús Vidal, María Jesús Pascual, Beatriz Quereda, Juan Manuel Sancho, Sr., MD, Joaquín Díaz-Mediavilla, Javier López, Eulogio Conde, MD, PhD, Isidro Jarque, MD, Natalia Alonso, María José Ramirez, María José Sayas, María José Requena, Antonio Salar, MD, José David González, MD, Eva González-Barca, MD, PhD, Reyes Arranz, Jesús F San Miguel, Dolores Caballero, MD
Journal: Blood
Blood (2012) 120 (21): 3142.
https://doi.org/10.1182/blood.V120.21.3142.3142
Published: 2012
Journal Articles

Preferential Acquision of N-Glycosylation Sites in the VDJ Region in Germinal Center B-Cell-Like Difusse Large B-Cell Lymphoma

Free
Miguel Alcoceba, Elena Sebastián, Ana Balanzategui, Luis Marín, Santiago Montes-Moreno, Teresa Flores, Noemí Puig, M. Eugenia Sarasquete, M. Carmen Chillón, Cristina Jiménez, Rocío Corral, Eva González-Barca, M. Dolores Caballero, Jesús F. San Miguel, Ramón García-Sanz, Marcos González
Journal: Blood
Blood (2012) 120 (21): 1589.
https://doi.org/10.1182/blood.V120.21.1589.1589
Published: 2012
Journal Articles

Risk Adapted-High Dose Therapies Modulate the Impact of Biological Classification in Diffuse Large B Cell Lymphoma Prognosis. Analysis of Biological Markers in Patients From Clinical Trials in Geltamo and Gotel Spanish Collaborative Groups.

Free
Santiago Montes-Moreno, Ana Batlle, MD, Sonia Gonzalez de Villambrosia, MD, Beatriz Sanchez-Espiridión, PhD, Laura Cereceda, Eva González-Barca, Purroy Noelia, MD, Emilia Pardal, Elena Sebastian, Alejandro Martin, Carlos Grande, Francisco Mazorra, MD, Andrés Insunza, Antonio Rueda, MD, Marta Llanos, MD, Jose Gomez Codina, MD, Francisco Ramon Garcia Arroyo, MD, Dolores Caballero, MD, Eulogio Conde, Andrés Lopez, MD, Mariano Provencio, Miguel Piris, MD
Journal: Blood
Blood (2012) 120 (21): 2672.
https://doi.org/10.1182/blood.V120.21.2672.2672
Published: 2012
Journal Articles

Relationship Between HLA Class I and II Polymorphisms with Susceptibility and Clinical Outcome in Diffuse Large B-Cell Lymphoma.

Free
Miguel Alcoceba, Elena Sebastián, Luis Marín, Ana Balanzategui, M. Dolores Caballero, Eva González-Barca, Emilia Pardal, Alejandro Martin, Carlos Grande, José Luis Bello, Carmen Albo, Fatima de la Cruz, Carlos Panizo, Eulogio Conde, M. Eugenia Sarasquete, M. Carmen Chillón, Cristina Jiménez, Noemí Puig, Rocío Corral, Jesús F. San Miguel, Ramón García-Sanz, Marcos González
Journal: Blood
Blood (2012) 120 (21): 2680.
https://doi.org/10.1182/blood.V120.21.2680.2680
Published: 2012
Journal Articles

Long-Term Follow-up of Patients with HIV-Related Diffuse Large B-Cell Lymphoma (DLBCL) Treated in the Phase II Study with Rituximab and CHOP (R-CHOP)

Free
Josep-Maria Ribera, MD, PhD, Mireia Morgades, Albert Oriol, Eva González-Barca, MD, Pilar Miralles, Armando Lopez-Guillermo, Santiago Gardella, Andrés López, Eugènia Abella, Blanca Xicoy, MD, Marta Garcia, Evarist Feliu, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4980.
https://doi.org/10.1182/blood.V118.21.4980.4980
Published: 2011
Journal Articles

Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) After Upfront Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM): Final Results of a Multicenter Phase II Trial On Behalf of the Spanish CLL Study Group (GELLC)

Free
Francesc Bosch, MD, PhD, Pau Abrisqueta, Neus Villamor, MD. PhD, María José Terol, MD, PhD, Eva González-Barca, MD, Marcos González, MD, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose A. Garcia-Marco, MD, PhD, Yolanda Gonzalez, Felix Carbonell, MD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, Ana Muntanola, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD. PhD
Journal: Blood
Blood (2011) 118 (21): 293.
https://doi.org/10.1182/blood.V118.21.293.293
Published: 2011
Journal Articles

Prognostic Value of cMYC Gene Abnormalities in Diffuse Large B Cell Lymphoma Treated with Chemo-Immunotherapy

Free
Ana Batlle López, MD, PhD, Sonia Glez de Villambrosia, MD, Santiago Montes-Moreno, MD, Francisco Mazorra, MD, Andrés Insunza, MD, Anabel Sáez, MD, Carlos Montalban, MD, PhD, Lydia Sánchez, Juan F. Garcia, MD, Eva González-Barca, MD, A López, MD, MC Ruiz-Marcellan, MD, Manuela Mollejo, MD, Carlos Grande, MD, Cherie H. Dunphy, MD, ED His, MD, Ronald S. Go, MD, Carlo Visco, MD, Zijun Y. Xu-Monette, PhD, Ken H. Young, MD, Miguel Piris, MD, Eulogio Conde, Sr., MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2664.
https://doi.org/10.1182/blood.V118.21.2664.2664
Published: 2011
Journal Articles

Clinical and Biological Prognostic Factors Evaluation of Diffuse Large B-Cell Lymphoma Patients Relapsed or Refractory After Previous Line with Rituximab Plus Chemotherapy. Results of the Study PRO-R-IPI (NCT01369784),

Free
Carlos Panizo, MD, Anny Jaramillo, MD, Gonzalo Gutierrez-Garcia, Francisco Javier Díaz, Eva González-Barca, MD, Raquel de Oña, Nerea Castro, Juan Manuel Sancho, María Flor García-Alvarez, Blanca Sanchez-Gonzalez, MD, PhD, Francisco Javier Peñalver, Jimena Cannata-Ortiz, Manuel Espeso, María José Requena, Santiago Gardella, Soledad Durán, Ana Pilar González-Rodríguez, Ricardo García-Muñoz, Maurizio Bendandi, MD, PhD, Dolores Caballero, MD
Journal: Blood
Blood (2011) 118 (21): 3654.
https://doi.org/10.1182/blood.V118.21.3654.3654
Published: 2011
Journal Articles

Impact of Rituximab-Based Therapy After Histological Transformation on High-Dose Therapy and Autologous Stem Cell Transplantation in Follicular Transformed Lymphomas

Free
Jose Manuel Calvo-Villas, Alejandro Martín, Carlos Panizo, MD, Juan Manuel Sancho, Alba Redondo, José David González-Sanmiguel, Blanca Sanchez Gonzalez, MD, Maria José Requena, Eva González-Barca, MD, María José Rodríguez-Salazar, Nerea Castro, Viviana Paredes, Jorge Gayoso, Dolores Caballero, MD
Journal: Blood
Blood (2011) 118 (21): 4478.
https://doi.org/10.1182/blood.V118.21.4478.4478
Published: 2011
Journal Articles

Acadesine for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL): A Multicentre Phase I/II Study

Free
Eric Van den Neste, Bruno Cazin, Ann Janssens, M.D., Eva González-Barca, María José Terol, Vincent Levy, Jaime Pérez de Oteyza, Pierre Zachee, Andrew Saunders, Mercè de Frias, Clara Campàs
Journal: Blood
Blood (2010) 116 (21): 4625.
https://doi.org/10.1182/blood.V116.21.4625.4625
Published: 2010
Journal Articles

Liver Infiltration In Splenic Marginal Zone Lymphoma: Prevalence and Prognostic Implication

Free
Eva Domingo-Domenech, Vicente Romagosa, Eva González-Barca, Marta Rodriguez-Aliberas, Ana Oliveira, Esmeralda de la Banda, Santiago Mercadal, Jose Sarra, Jose Petit, Alberto Fernandez de Sevilla, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4137.
https://doi.org/10.1182/blood.V116.21.4137.4137
Published: 2010
Journal Articles

AICAR Induces Apoptosis In B Lymphocytes From Balb/c Mice and Its Effect In Chronic Lymphocytic Leukemia Cells Is Synergic or Additive with Current Chemotherapy

Free
Diana M González-Gironès, Antonio F Santidrián, Daniel Iglesias-Serret, Ana M Cosialls, Alba Pérez-Perarnau, Camila Rubio-Patiño, Mercè de Frias, Alberto Fernandez de Sevilla, MD, PhD, Eva González-Barca, Esmeralda de la Banda, Gabriel Pons, Clara Campàs, Joan Gil
Journal: Blood
Blood (2010) 116 (21): 1815.
https://doi.org/10.1182/blood.V116.21.1815.1815
Published: 2010
Journal Articles

Rituximab Maintenance In Patients with Chronic Lymphocytic Leukemia (CLL) Sustains the Response Obtained After First-Line Treatment with Rituximab Plus Fludarabine, Cyclophosphamide, and Mitoxantrone (R-FCM).

Free
Francesc Bosch, MD, PhD, Neus Villamor, Pau Abrisqueta, MD, María José Terol, Eva González-Barca, Marcos González, Christelle Ferrà, Eugenia Abella, Julio Delgado, Jose A Garcia-Marco, MD, PhD, Yolanda Gonzalez, Felix Carbonell, MD, Secundino Ferrer, Encarna Monzo, MD, Isidro Jarque, MD, Ana Muntanola, Mireia Constants, Lourdes Escoda, Emili Montserrat, MD
Journal: Blood
Blood (2010) 116 (21): 1382.
https://doi.org/10.1182/blood.V116.21.1382.1382
Published: 2010
Journal Articles

Predictive Value for Event-Free Survival of Interim 18F-FDG-PET In Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 6 Cycles of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim as First-Line Treatment: An Open-Label Clinical Trial In Spain.

Free
Eva González-Barca, Miguel Canales, MD, PhD, María Jesús Vidal, Albert Oriol, Antonio Salar, Joan Bargay, Montse Cortés, Juan Coya, José Francisco Tomás, Andrés López, José Javier Sánchez, Eva Donato, Andrés Llorente, Secundino Ferrer, Dolores Caballero
Journal: Blood
Blood (2010) 116 (21): 2793.
https://doi.org/10.1182/blood.V116.21.2793.2793
Published: 2010
Journal Articles

Rituximab Maintenance Treatment After Combined Fludarabine, Cyclophosphamide and Rituximab In Previously Untreated Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (CLL): Interim Analysis of An Ongoing Phase II Multicenter Trial On Behalf of the Spanish CLL Study Group (GELLC)

Free
Jose A Garcia-Marco, MD, PhD, Javier Lopez-Jimenez, MD, Secundino Ferrer, MD, Pilar Giraldo, MD, PhD, Eva González-Barca, MD, Belen Navarro, MD, Eulogio Conde, MD, PhD, Marcos González, Jose L. Guzman, MD, Ernesto Perez, MD, Javier De la Serna, MD, PhD, Mar Osma, MD, Guillermo Deben, MD, Encarna Monzo, MD, Raquel de Paz, MD, M. Angeles Ruiz, MD, Francisco-Javier Penalver, Isidro Jarque, MD, Helena Bañas, MD, M. Carmen Fernandez, MD, Rafael Martinez, MD, Carmen Burgaleta, MD, Jaime Perez de Oteiza, MD, M.Angeles Andreu, MD, Ana Carral, MD, Inmaculada Fuentes, MD, Eva Donato, MD, Paola Leon, MD, Felix Carbonell, MD, Jose A. Garcia-Vela, MD
Journal: Blood
Blood (2010) 116 (21): 2448.
https://doi.org/10.1182/blood.V116.21.2448.2448
Published: 2010
Journal Articles

Efficacy and Safety of Liposomal Cytarabine as Intrathecal Prophylaxis in Patients with Diffuse Large B Cell Lymphoma at High Risk of CNS Involvement: A Multicentric Study Including 80 Patients in Spain.

Free
Adolfo de la Fuente, Sr., Antonio Salar, MD, PhD, Carlos Panizo, MD, Belen Navarro, Sr., Teresa Olave, María Jesus Peñarrubia, MD, JoaquÃn Herrero, MD, PhD, Jose Francisco Tomas, Miguel Canales, Eva González-Barca
Journal: Blood
Blood (2009) 114 (22): 1663.
https://doi.org/10.1182/blood.V114.22.1663.1663
Published: 2009
Journal Articles

AICAR Induces Apoptosis in Chronic Lymphocytic Leukemia Cells through the Mitochondrial Pathway and Independently of p53 Pathway and AMPK Activation.

Free
Joan Gil, PhD, Antonio F Santidrián, PhD, Diana M González-Gironès, PhD, Daniel Iglesias-Serret, PhD, Llorenç Coll-Mulet, PhD, Ana M Cosialls, PhD, Mercè de Frias, PhD, Clara Campàs, PhD, Eva González-Barca, MD, PhD, Esther Alonso, MD, Alberto Fernandez de Sevilla, MD, PhD, Benoit Viollet, PhD, Gabriel Pons, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4819.
https://doi.org/10.1182/blood.V114.22.4819.4819
Published: 2009
Journal Articles

Clinical Significance of the Presence of Occult CNS Involvement Assessed by Cytofluorometry in Patients with Non Hodgkin’s Lymphoma and High Risk of CNS Relapse

Free
Juan-Manuel Sancho, Alberto Orfao, Olga García, Carlos Panizo, Elena Pérez, Mireia Morgades, Antonio Salar, José-Antonio García-Vela, Natalia Alonso, Eva González-Barca, Josefa Plaza, Dolores Caballero, Mariano Provencio, Miguel Marin, Teresa Molero, Josep-Maria Ribera
Journal: Blood
Blood (2008) 112 (11): 5270.
https://doi.org/10.1182/blood.V112.11.5270.5270
Published: 2008